Markets:

Overview

News

Currencies

International

Treasuries

Repligen Corporation - Common Stock (NQ:RGEN)

160.05 -3.58 (-2.19%)

Streaming Delayed Price Updated: 4:00 PM EST, Jan 28, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Repligen Corporation - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 Next >

Top-Rated Stocks: Lantheus Stock Sees Composite Rating Climb To 96 ↗

September 01, 2022

Top-rated Lantheus stock saw an improvement in its IBD SmartSelect Composite Rating Thursday, from 94 to 96.

Via Investor's Business Daily

Golden Cross Appears Before Repligen Investors ↗

August 26, 2022

If history is any guide, there may be good fortune ahead for shares of Repligen (NASDAQ:RGEN). A so-called "golden cross" has formed on its chart and, not surprisingly, this could be bullish for the...

Via Benzinga

Glaukos Stock Scores Rising Price Performance With Jump To 91 RS Rating ↗

August 16, 2022

On Tuesday, Glaukos stock hit an key technical milestone, with its Relative Strength Rating climbing to 91, up from 87 the day before.

Via Investor's Business Daily

Catalent-Repligen Merger 'Seems Unlikely,' This Analyst Says ↗

August 12, 2022

Via Benzinga

Expert Ratings for Repligen ↗

August 03, 2022

Analysts have provided the following ratings for Repligen (NASDAQ:RGEN) within the last quarter:

Via Benzinga

Uber, Lyft And Some Other Big Stocks Recording Gains On Tuesday ↗

August 03, 2022

U.S. stocks closed lower on Tuesday, with the Dow Jones dropping more than 400 points. Here is the list of some big stocks moving higher in the previous session.

Via Benzinga

Repligen: Q2 Earnings Insights ↗

August 02, 2022

Repligen (NASDAQ:RGEN) reported its Q2 earnings results on Tuesday, August 2, 2022 at 07:30 AM. Here's what investors need to know about the announcement.

Via Benzinga

Recap: Repligen Q1 Earnings ↗

April 27, 2022

Repligen (NASDAQ:RGEN) reported its Q1 earnings results on Wednesday, April 27, 2022 at 07:30 AM. Here's what investors need to know about the announcement.

Via Benzinga

Stock Market Rally Mixed As Oil Prices Fall, Job Growth Hot: Weekly Review ↗

August 05, 2022

The Nasdaq and small caps rose while the S&P 500 is hitting resistance.

Via Investor's Business Daily

Biotech Daily: Trial Setback For Eliem Therapeutics, Allarity Drops Work On Cancer Monotherapies, Axcella Aces Long COVID Study ↗

August 02, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours:

Via Benzinga

Stocks That Hit 52-Week Lows On Tuesday ↗

April 26, 2022

During Tuesday, 581 stocks hit new 52-week lows. Interesting Highlights From Today's 52-Week Lows Meta Platforms (NASDAQ:FB) was the biggest company on a market cap basis to set a new 52-week low.

Via Benzinga

Why Shares Of Cannabis Companies Traded Higher; Here Are 101 Biggest Movers From Yesterday ↗

August 03, 2022

Gainers MMTec, Inc. (NASDAQ: MTC) shares gained 390.6% to close at $7.85 on Tuesday amid volatility in nano-cap Chinese stocks.

Via Benzinga

Why Applied DNA Sciences Is Trading Higher By 166%, Here Are 75 Stocks Moving In Tuesday's Mid-Day Session ↗

August 02, 2022

Gainers AMTD IDEA Group (NYSE: AMTD) shares jumped 284% to $8.00 after jumping 18% on Monday. The company owns 90%+ of AMTD Digital.

Via Benzinga

Silk Road Medical Stock Clears Key Benchmark, Hitting 90-Plus RS Rating ↗

July 22, 2022

Silk Road Medical stock saw a welcome improvement to its Relative Strength (RS) Rating on Friday, with an upgrade from 69 to 90.

Via Investor's Business Daily

Earnings Scheduled For August 2, 2022 ↗

August 02, 2022

Companies Reporting Before The Bell • Ferrari (NYSE:RACE) is expected to report quarterly earnings at $1.27 per share on revenue of $1.22 billion.

Via Benzinga

Tesla, Danaher And Some Other Big Gainers From Yesterday ↗

July 22, 2022

U.S. stocks closed higher on Thursday, with the Nasdaq Composite jumping around 1.4%. Here is the list of some big stocks recording gains in the previous session.

Via Benzinga

This Healthcare Stock Jumped 110%; Here Are 64 Biggest Movers From Yesterday ↗

July 22, 2022

Gainers Virax Biolabs Group Limited (NASDAQ: VRAX) shares climbed 264% to close at $18.20 on Thursday. The company offered shares at an expected price of $5.00 per share with an insider lock-up period...

Via Benzinga

Why Is Super Micro Computer Higher By More Than 13%? 42 Stocks Moving In Thursday's Mid-Day Session ↗

July 21, 2022

Gainers Virax Biolabs Group Limited (NASDAQ: VRAX) shares jumped 364.3% to $23.22. The company offered shares at an expected price of $5.00 per share with an insider lock-up period of 180 days ending...

Via Benzinga

Thoughts For Thursday: Which Way Through Uncertainty? ↗

June 30, 2022

Markets are trying to maintain resistance levels generated from last week's rally, but finding the path to doing so is proving to be no easy matter.

Via Talk Markets

Happy Birthday, iphone! ↗

June 29, 2022

Exactly a decade and a half ago to the day, what is now the staple of the smartphone market first hit the shelves.

Via Talk Markets

Benzinga's Top Ratings Upgrades, Downgrades For July 20, 2022 ↗

July 20, 2022

Upgrades

Via Benzinga

10 Biggest Price Target Changes For Thursday ↗

April 28, 2022

Needham lowered MKS Instruments, Inc. (NASDAQ: MKSI) price target from $185 to $175. MKS Instruments shares rose 3.6% to $116.01 in pre-market trading.

Via Benzinga

61 Biggest Movers From Yesterday ↗

April 28, 2022

Gainers Vivakor, Inc. (NASDAQ: VIVK) shares jumped 113.5% to close at $3.65 on Wednesday after the company announced it has signed a 10-year contract with Hot Oil Transport with...

Via Benzinga

38 Stocks Moving In Wednesday's Mid-Day Session ↗

April 27, 2022

Gainers Vivakor, Inc. (NASDAQ: VIVK) gained 154% to $4.3550 after the company announced it has signed a 10-year contract with Hot Oil Transport with a potential value of...

Via Benzinga

The Daily Biotech Pulse: Molecular Partners Plunges On Double Bad News, Pfizer/BioNTech Seek Nod For COVID-19 Shot In Kids, Pfizer Invests In Zentalis ↗

April 27, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours.

Via Benzinga

Repligen Earnings Conference Call Is Coming Up, Here's What You Need To Know ↗

April 20, 2022

Repligen (NASDAQ:RGEN) will host a conference call at 08:30 AM ET on April 27, 2022, to discuss Q1 2022 earnings results. How to Attend Repligen (RGEN) Conference Call Follow this link to access the...

Via Benzinga

Elephant Tracking: How to Spot the Market’s Next Mega Winners BEFORE They Take Off ↗

April 11, 2022

If you follow an elephant's tracks, you find an elephant. If you follow a large money manager, you'll find the winners they've identified.

Via InvestorPlace

Repligen Earnings Perspective: Return On Capital Employed ↗

February 18, 2022

Pulled from Benzinga Pro data, Repligen (NASDAQ:RGEN) showed a loss in earnings since Q3, totaling $29.11 million. Sales, on the other hand, increased by 4.66% to $186.52 million during Q4.

Via Benzinga

Earnings Scheduled For April 27, 2022 ↗

April 27, 2022

Companies Reporting Before The Bell • Deutsche Bank (NYSE:DB) is projected to report earnings for its first quarter.

Via Benzinga

Stocks That Hit 52-Week Lows On Tuesday ↗

April 19, 2022

On Tuesday, 242 companies hit new 52-week lows. Noteworthy Mentions In Today's 52-Week Lows: The largest company in terms of market cap to set a new 52-week low was...

Via Benzinga

< Previous 1 2 3 4 5 6 7 8 9 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Repligen Corporation - Common Stock (NQ:RGEN)

All News about Repligen Corporation - Common Stock

Resources